46 results on '"Altrichter, Jens"'
Search Results
2. Purified Granulocyte Concentrates from Buffy Coats with Extended Storage Time.
3. Algorithm-Based Liquid Formulation Development Including a DoE Concept Predicts Long-Term Viral Vector Stability
4. Purified granulocytes in extracorporeal cell therapy: A multifaceted approach to combat sepsis-induced immunoparalysis.
5. Granulocyte products: The saga continues
6. Extracorporeal therapy of sepsis by purified granulocyte concentrates - ex vivo circulation model
7. Extracorporeal therapy of sepsis by purified granulocyte concentrates—ex vivo circulation model
8. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance
9. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates
10. Therapeutic apheresis in sepsis
11. Nano-coating protects biofunctional materials
12. Stimulation of Fas signaling down-regulates activity of neutrophils from major trauma patients with SIRS
13. Prolonged storage of purified granulocyte concentrates: Introduction of a new purification method
14. Use of preconditioned human phagocytes for extracorporeal adsorption of viruses
15. Prolonged storage of purified granulocyte concentrates: Introduction of a new purification method
16. Impaired cell functions of hepatocytes incubated with plasma of septic patients
17. Neutrophil-derived circulating free DNA (cf-DNA/NETs), a potential prognostic marker for mortality in patients with severe burn injury
18. The clinical value of neutrophil extracellular traps
19. Diagnostic Accuracy of Neutrophil-Derived Circulating Free DNA (cf-DNA/NETs) for Septic Arthritis
20. Use of Human Preconditioned Phagocytes for Extracorporeal Immune Support: Introduction of a Concept
21. Extracorporeal immune therapy with immobilized agonistic anti-Fas antibodies leads to transient reduction of circulating neutrophil numbers and limits tissue damage after hemorrhagic shock/resuscitation in a porcine model
22. Effects of bioreactor‐oxygenation during extracorporeal granulocytes treatment in septic patients
23. Impaired cell viability and functionality of hepatocytes after incubation with septic plasma
24. Impaired Cell Viability and Functionality of Hepatocytes After Incubation With Septic Plasma—Results of a Second Prospective Biosensor Study
25. Amino Acid-Based Advanced Liquid Formulation Development for Highly Concentrated Therapeutic Antibodies Balances Physical and Chemical Stability and Low Viscosity
26. Effects of Bioreactor-Oxygenation During Extracorporeal Granulocytes Treatment in Septic Patients
27. Bioartificial therapy of sepsis
28. Role of different replacement fluids during extracorporeal treatment in a pig model of sepsis
29. Bioartificial Therapy of Sepsis: Changes of Norepinephrine-Dosage in Patients and Influence on Dynamic and Cell Based Liver Tests during Extracorporeal Treatments
30. Extracorporeal immune therapy with immobilized agonistic anti-Fas antibodies leads to transient reduction of circulating neutrophil numbers and limits tissue damage after hemorrhagic shock/resuscitation in a porcine model
31. Role of Different Replacement Fluids During Extracorporeal Treatment in a Pig Model of Sepsis
32. Plasma Separation by Centrifugation and Subsequent Plasma Filtration: Impact on Survival in a Pig Model of Sepsis
33. Selection of proangiogenic ascorbate derivatives and their exploitation in a novel drug-releasing system for wound healing
34. Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study
35. Kynurenine inhibits chondrocyte proliferation and is increased in synovial fluid of patients with septic arthritis
36. Extracorporeal immune therapy with immobilized agonistic anti-Fas antibodies leads to transient reduction of circulating neutrophil numbers and limits tissue damage after hemorrhagic shock/resuscitation in a porcine model
37. Mcl-1-Mediated Impairment of the Intrinsic Apoptosis Pathway in Circulating Neutrophils from Critically Ill Patients Can Be Overcome by Fas Stimulation
38. Safety Evaluation for a Cell‐based Immune Support System in an Ex Vivo Rat Model of Gram‐negative Sepsis
39. INCREASED PLASMA KYNURENINE VALUES AND KYNURENINE-TRYPTOPHAN RATIOS AFTER MAJOR TRAUMA ARE EARLY INDICATORS FOR THE DEVELOPMENT OF SEPSIS
40. Extracorporeal cell therapy with granulocytes in a pig model of Gram-positive sepsis
41. Increased plasma kynurenine values and kynurenine
42. NEUTROPHIL-DERIVED CIRCULATING FREE DNA (cf-DNA/NETs)
43. SEPSIS TREATMENT BY EXTRACORPOREAL PHAGOCYTOSIS ASSIST: RESULTS OF AN EX-VIVO ANIMAL MODEL
44. Phosphatidylinositol Hydrolysis and an Increase in Ca2+ Concentration in the Signal‐Transduction Process Triggered by Murine FcγRIII are not Required for Protein Kinase C Translocation
45. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance.
46. Role of different replacement fluids during extracorporeal treatment in a pig model of sepsis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.